Enhertu notched another win for AstraZeneca and Daiichi Sankyo that could see uptake moved slightly earlier in a specific ...

Pharma secures €15M in second closing: The fundraise, which was backed by private investors, will be used to support the French biotech as it uses its “startup studio’s model” to develop single ...

Flagship-incubated Repertoire Immune Medicines has lined up an autoimmune disease pact with Bristol Myers Squibb, marking the ...

It was a positive week for the European Medicines Agency’s human medicines committee (CHMP), which recommended the approval ...

Ipsen’s new sponsored TikTok features the popular “Of course” trend and two social influencers, but with a rare disease twist ...

AbbVie's effort to protect Humira's market share is getting expensive. On Friday, the company announced a 40% decline in the ...

UCB is shaking up its leadership team “to better align with its commitment to growth and innovation, and to better address ...

We’re in a frothy time,” acknowledges Alexandra Snyder, the head of R&D at Generate:Biomedicines. Generate is one of the ...

Cigna’s health services arm Evernorth said on Thursday that it plans to offer a cheaper copycat of AbbVie’s blockbuster drug ...

Walgreens said Thursday it’s getting into cell and gene therapy pharmacy services and bringing its specialty pharmacy under a ...

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add ...

Sen. Bernie Sanders (I-VT) is calling on global pharmaceutical leaders to get behind proposals laid out in a World Health ...